Veterinary Excipients Market to Grow with a CAGR of 4.36% through 2029F
Rising prevalence of animal diseases is expected to drive the Global
Veterinary Excipients Market growth in the forecast period, 2025-2029.
According to TechSci Research report, “Veterinary Excipients Market –
Global Industry Size, Share, Trends, Competition Forecast &
Opportunities, 2029F”, the Global Veterinary Excipients Market stood at USD
1.27 Billion in 2023 and is anticipated to grow with a CAGR of 4.36% in the
forecast period through 2029. The prevalence of various diseases and health
conditions among animals is another significant driver propelling the growth of
the Veterinary Excipients Market. Factors such as intensification of livestock
production, changes in farming practices, and increasing urbanization
contribute to the spread of infectious diseases among animals.
Advancements in pharmaceutical technology and formulation techniques are
revolutionizing the veterinary pharmaceuticals industry, driving innovation and
expanding the repertoire of excipients available for veterinary applications.
Novel drug delivery systems, such as controlled-release formulations and
nanoparticles, are enabling more precise dosing regimens and enhancing the
bioavailability of active ingredients in veterinary medicines. Excipients play
a pivotal role in optimizing the performance and stability of these advanced
drug delivery systems, driving demand for specialized excipients tailored to
the unique physiological characteristics of animals.
Browse over XX market data Figures spread through XX Pages and an
in-depth TOC on "Global Veterinary Excipients Market”
The Global Veterinary Excipients Market is segmented into application, animal type, end use,
chemical group, regional distribution, and company.
Based on application, In 2023, the global veterinary
excipients market witnessed a notable emergence of the pharmaceuticals segment
as the dominant force. Veterinary excipients are essential components in
pharmaceutical formulations, aiding in the delivery, stability, and efficacy of
active pharmaceutical ingredients (APIs) in veterinary medicines. The
pharmaceuticals segment surged ahead due to several factors. The rising demand
for advanced veterinary medications to address a spectrum of animal health
issues propelled the growth of this segment. As pet ownership continues to rise
worldwide, coupled with increasing concerns regarding livestock health in food
production, the demand for pharmaceuticals tailored for veterinary use soared.
Moreover, advancements in
pharmaceutical formulations, including sustained-release dosage forms and novel
drug delivery systems, contributed to the segment's dominance. Veterinary
pharmaceutical manufacturers focused on developing formulations that enhance
patient compliance, reduce dosing frequency, and improve therapeutic outcomes,
thereby driving the demand for high-quality excipients. Additionally,
regulatory initiatives aimed at ensuring the safety, efficacy, and quality of
veterinary pharmaceuticals further stimulated market growth. Compliance with
stringent regulatory standards necessitates the use of premium-grade excipients
in veterinary formulations, bolstering the pharmaceuticals segment.
Based on region, North
America is anticipated to dominate the global veterinary excipients market.
This dominance can be attributed to several factors, including the presence of
a well-established veterinary healthcare infrastructure, high adoption rates of
advanced veterinary medicines, and robust research and development activities
in the region. Additionally, increasing pet ownership rates, stringent
regulatory standards ensuring the quality and safety of veterinary
pharmaceuticals, and growing investments in the development of novel veterinary
drug formulations contribute to the region's prominence. Furthermore, strategic
collaborations between key industry players and academic institutions for the
development of innovative excipients and formulations bolster market growth.
Major companies operating in Global Veterinary Excipients Market
are:
·
Croda International plc
·
JRS PHARMA GmbH + Co. KG
·
Colorcon
·
Quality Chemicals S.L
·
IOI Oleochemical
·
Lipoid GmbH
·
Gattefossé SAS
·
Azelis Group
·
Ashland Global Holdings Inc.
·
Spectrum Chemical Mfg. Corp.
Download Free Sample Report
Customers can also request for 10% free
customization on this report
“The Global Veterinary
Excipients Market is poised for significant growth in the coming years.
Technological advancements in pharmaceutical formulation are expected to drive
innovation in excipient development, enabling the creation of more effective
and tailored veterinary medications. Additionally, expanding regulatory
approvals and harmonization efforts are likely to facilitate market access and
encourage investment in excipient research and development. Furthermore, the
emergence of novel drug delivery systems and the adoption of sustainable
farming practices are anticipated to further stimulate demand for excipients in
veterinary pharmaceuticals”, said Mr. Karan Chechi, Research Director of
TechSci Research, a research-based management consulting firm.
“Veterinary Excipients Market - Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Application (Biologics, Pharmaceuticals, Medicated Feed Additives), By Chemical Group (Polymers, Alcohols, Lipids, Mineral Salts, Others), By Animal Type (Production Animals, Companion Animals), By End Use (Solubilizers/ Solvents, Binders, Stabilizers, Coating, Diluents & fillers, Others), By Region and Competition, 2019-2029F”, has evaluated the future
growth potential of Global Veterinary Excipients Market and provides statistics
& information on market size, structure and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global Veterinary Excipients Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com